S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
The Strategic Gold Play You Haven't Heard About (Ad)
Stock market today: World shares are mixed, Chinese markets surge, after latest retreat on Wall St
Analysts Recommend These Mining Stocks Before Metal Prices Rally
The Strategic Gold Play You Haven't Heard About (Ad)
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Turkey’s central bank hikes interest rates again in further shift in economic policies
The Strategic Gold Play You Haven't Heard About (Ad)
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
Renowned Federal Judge, 96, Faces Yearlong Suspension For Refusing to Retire
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
The Strategic Gold Play You Haven't Heard About (Ad)
Stock market today: World shares are mixed, Chinese markets surge, after latest retreat on Wall St
Analysts Recommend These Mining Stocks Before Metal Prices Rally
The Strategic Gold Play You Haven't Heard About (Ad)
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Turkey’s central bank hikes interest rates again in further shift in economic policies
The Strategic Gold Play You Haven't Heard About (Ad)
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
Renowned Federal Judge, 96, Faces Yearlong Suspension For Refusing to Retire
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
The Strategic Gold Play You Haven't Heard About (Ad)
Stock market today: World shares are mixed, Chinese markets surge, after latest retreat on Wall St
Analysts Recommend These Mining Stocks Before Metal Prices Rally
The Strategic Gold Play You Haven't Heard About (Ad)
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Turkey’s central bank hikes interest rates again in further shift in economic policies
The Strategic Gold Play You Haven't Heard About (Ad)
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
Renowned Federal Judge, 96, Faces Yearlong Suspension For Refusing to Retire
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
The Strategic Gold Play You Haven't Heard About (Ad)
Stock market today: World shares are mixed, Chinese markets surge, after latest retreat on Wall St
Analysts Recommend These Mining Stocks Before Metal Prices Rally
The Strategic Gold Play You Haven't Heard About (Ad)
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Turkey’s central bank hikes interest rates again in further shift in economic policies
The Strategic Gold Play You Haven't Heard About (Ad)
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
Renowned Federal Judge, 96, Faces Yearlong Suspension For Refusing to Retire
NYSE:MD

Pediatrix Medical Group (MD) Stock Forecast, Price & News

$12.57
-0.01 (-0.08%)
(As of 09/21/2023 ET)
Compare
Today's Range
$12.50
▼
$12.73
50-Day Range
$12.51
▼
$14.95
52-Week Range
$12.40
▼
$19.63
Volume
340,384 shs
Average Volume
638,939 shs
Market Capitalization
$1.06 billion
P/E Ratio
10.14
Dividend Yield
N/A
Price Target
$16.60
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Pediatrix Medical Group MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
32.1% Upside
$16.60 Price Target
Short Interest
Healthy
3.81% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
9.09%
From $1.43 to $1.56 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.45 out of 5 stars

Medical Sector

192nd out of 965 stocks

Hospitals Industry

3rd out of 3 stocks

See Top Rated MarketRank™ Stocks Here

MD stock logo

About Pediatrix Medical Group (NYSE:MD) Stock

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

MD Price History

MD Stock News Headlines

September 5, 2023 | finance.yahoo.com
Is Pediatrix Medical Group (MD) Too Good to Be True? A Comprehensive Analysis of a Potential ...
August 8, 2023 | seekingalpha.com
Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold
September 22, 2023 | Edge On The Street (Ad)
The Strategic Gold Play You Haven't Heard About
Experts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure.
August 4, 2023 | msn.com
Is Cardiac Arrest Common in Younger People, and Do Athletics Play a Role?
August 3, 2023 | washingtonpost.com
Pediatrix Medical Group: Q2 Earnings Snapshot
August 3, 2023 | msn.com
Pediatrix Medical Group (MD) Meets Q2 Earnings Estimates
July 31, 2023 | yahoo.com
Yes, You Can Get Pregnant If You're Already Pregnant—Here's How It Happens
July 27, 2023 | yahoo.com
How to Successfully Dream Feed Your Baby
September 22, 2023 | Edge On The Street (Ad)
The Strategic Gold Play You Haven't Heard About
Experts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure.
July 18, 2023 | finance.yahoo.com
MD vs. PGNY: Which Stock Is the Better Value Option?
July 18, 2023 | finance.yahoo.com
Pediatrix Medical Group 2023 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 3, 2023
June 1, 2023 | finance.yahoo.com
Why Is Pediatrix Medical Group (MD) Down 4.9% Since Last Earnings Report?
May 31, 2023 | fool.com
Pediatrix Medical Group (NYSE: MD)
May 24, 2023 | finance.yahoo.com
Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
May 9, 2023 | nasdaq.com
Truist Securities Maintains Pediatrix Medical Group (MD) Hold Recommendation
May 6, 2023 | seekingalpha.com
Pediatrix: P&L Still Burdened From RCM Overhang, Reiterate Hold
May 5, 2023 | finance.yahoo.com
Pediatrix (MD) Down 4.2% Despite Q1 Earnings & Revenue Beat
May 4, 2023 | msn.com
Looking Into Pediatrix Medical Group's Return On Capital Employed
May 4, 2023 | finance.yahoo.com
Pediatrix Board Appoints Sylvia Young as Independent Director
May 3, 2023 | finance.yahoo.com
Pediatrix Medical Group to Present at 2023 Bank of America Health Care Conference
May 3, 2023 | finance.yahoo.com
Q1 2023 Pediatrix Medical Group Inc Earnings Call
May 2, 2023 | chron.com
Pediatrix Medical Group: Q1 Earnings Snapshot
May 2, 2023 | msn.com
Pediatrix Medical Group (MD) Tops Q1 Earnings and Revenue Estimates
May 1, 2023 | msn.com
A Preview Of Pediatrix Medical Group's Earnings
April 26, 2023 | finance.yahoo.com
Pediatrix Medical Group (NYSE:MD) sheds US$74m, company earnings and investor returns have been trending downwards for past five years
April 26, 2023 | finance.yahoo.com
Pediatrix Medical Group 2023 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 2, 2023
April 20, 2023 | uk.news.yahoo.com
Analysts Estimate Pediatrix Medical Group (MD) to Report a Decline in Earnings: What to Look Out for
See More Headlines
Receive MD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pediatrix Medical Group and its competitors with MarketBeat's FREE daily newsletter.

MD Company Calendar

Last Earnings
8/03/2023
Today
9/21/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Hospitals
Sub-Industry
Health Care Services
Sector
Medical
Current Symbol
NYSE:MD
Previous Symbol
NYSE:PDX
CUSIP
58502B10
CIK
893949
Web
www.mednax.com
Phone
(954) 384-0175
Fax
954-838-9961
Employees
5,250
Year Founded
1979

Price Target and Rating

Average Stock Price Forecast
$16.60
High Stock Price Forecast
$23.00
Low Stock Price Forecast
$14.00
Forecasted Upside/Downside
+32.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$1.24
Trailing P/E Ratio
10.14
Forward P/E Ratio
8.79
P/E Growth
1.93
Net Income
$66.33 million
Net Margins
5.16%
Pretax Margin
6.33%
Return on Equity
12.81%
Return on Assets
4.96%

Debt

Debt-to-Equity Ratio
0.71
Current Ratio
1.24
Quick Ratio
1.24

Sales & Book Value

Annual Sales
$1.97 billion
Price / Sales
0.54
Cash Flow
$2.01 per share
Price / Cash Flow
6.26
Book Value
$10.73 per share
Price / Book
1.17

Miscellaneous

Outstanding Shares
83,940,000
Free Float
82,263,000
Market Cap
$1.06 billion
Optionable
Optionable
Beta
1.72

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover
10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. James D. Swift M.D. (Age 61)
    CEO & Director
    Comp: $549.53k
  • Mr. C. Marc Richards (Age 52)
    Exec. VP & CFO
    Comp: $509.58k
  • Ms. Mary Ann E. Moore (Age 63)
    Exec. VP, Gen. Counsel & Sec.
    Comp: $542.02k
  • Dr. Curtis B. Pickert M.D. (Age 65)
    Exec. VP & COO
  • Mr. John C. PepiaMr. John C. Pepia (Age 60)
    Sr. VP & Chief Accounting Officer
  • Ms. Cheryl M. VanPatten
    Sr. VP & Chief Information Officer
  • Mr. Daniel Patrick Corcoran
    Sr. VP of Admin. & Managed Care
  • Mr. Charles W. Lynch C.F.A.
    Sr. VP of Fin., Strategy & Investor Relations
  • Ms. Meghan K. Lublin
    Sr. VP, Chief Brand & Communications Officer
  • Mr. Lee A. Wood (Age 55)
    Exec. VP of National & Market Operations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













MD Stock - Frequently Asked Questions

Should I buy or sell Pediatrix Medical Group stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pediatrix Medical Group in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" MD shares.
View MD analyst ratings or view top-rated stocks.

What is Pediatrix Medical Group's stock price forecast for 2023?

4 analysts have issued 1 year price objectives for Pediatrix Medical Group's stock. Their MD share price forecasts range from $14.00 to $23.00. On average, they expect the company's stock price to reach $16.60 in the next year. This suggests a possible upside of 32.1% from the stock's current price.
View analysts price targets for MD or view top-rated stocks among Wall Street analysts.

How have MD shares performed in 2023?

Pediatrix Medical Group's stock was trading at $14.86 at the beginning of the year. Since then, MD stock has decreased by 15.4% and is now trading at $12.57.
View the best growth stocks for 2023 here.

When is Pediatrix Medical Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our MD earnings forecast.

How were Pediatrix Medical Group's earnings last quarter?

Pediatrix Medical Group, Inc. (NYSE:MD) announced its earnings results on Thursday, August, 3rd. The company reported $0.39 EPS for the quarter, missing the consensus estimate of $0.40 by $0.01. The business had revenue of $500.60 million for the quarter, compared to analyst estimates of $495.88 million. Pediatrix Medical Group had a trailing twelve-month return on equity of 12.81% and a net margin of 5.16%. The company's revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.43 EPS.

What ETFs hold Pediatrix Medical Group's stock?

ETFs with the largest weight of Pediatrix Medical Group (NYSE:MD) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Invesco S&P SmallCap Health Care ETF (PSCH), Roundhill Acquirers Deep Value ETF (DEEP), Syntax Stratified SmallCap ETF (SSLY) and iShares U.S. Healthcare Providers ETF (IHF).AdvisorShares Dorsey Wright Short ETF (DWSH).

What is Mark S. Ordan's approval rating as Pediatrix Medical Group's CEO?

6 employees have rated Pediatrix Medical Group Chief Executive Officer Mark S. Ordan on Glassdoor.com. Mark S. Ordan has an approval rating of 34% among the company's employees. This puts Mark S. Ordan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Pediatrix Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pediatrix Medical Group investors own include NVIDIA (NVDA), AbbVie (ABBV), QUALCOMM (QCOM), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), Walt Disney (DIS), Wells Fargo & Company (WFC), Exxon Mobil (XOM) and Advanced Micro Devices (AMD).

What is Pediatrix Medical Group's stock symbol?

Pediatrix Medical Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "MD."

Who are Pediatrix Medical Group's major shareholders?

Pediatrix Medical Group's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.96%), Alliancebernstein L.P. (10.12%), Earnest Partners LLC (6.33%), Dimensional Fund Advisors LP (4.86%), State Street Corp (3.93%) and Geode Capital Management LLC (1.94%). Insiders that own company stock include James D Swift, John C Pepia, Mark S Ordan, Roger Mack Hinson, Roger Md Medel and Shirley A Weis.
View institutional ownership trends.

How do I buy shares of Pediatrix Medical Group?

Shares of MD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pediatrix Medical Group's stock price today?

One share of MD stock can currently be purchased for approximately $12.57.

How much money does Pediatrix Medical Group make?

Pediatrix Medical Group (NYSE:MD) has a market capitalization of $1.06 billion and generates $1.97 billion in revenue each year. The company earns $66.33 million in net income (profit) each year or $1.24 on an earnings per share basis.

How many employees does Pediatrix Medical Group have?

The company employs 5,250 workers across the globe.

How can I contact Pediatrix Medical Group?

Pediatrix Medical Group's mailing address is 1301 CONCORD TERRACE, SUNRISE FL, 33323. The official website for the company is www.mednax.com. The company can be reached via phone at (954) 384-0175, via email at charles_lynch@mednax.com, or via fax at 954-838-9961.

This page (NYSE:MD) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -